APA (7th ed.) Citation

Wehling, C., & Kirschfink, M. (2014). Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: Requirement for comprehensive complement analysis. Journal of thrombosis and haemostasis, 12(9), . https://doi.org/10.1111/jth.12639

Chicago Style (17th ed.) Citation

Wehling, Cyrill, and Michael Kirschfink. "Tailored Eculizumab Regimen for Patients with Atypical Hemolytic Uremic Syndrome: Requirement for Comprehensive Complement Analysis." Journal of Thrombosis and Haemostasis 12, no. 9 (2014). https://doi.org/10.1111/jth.12639.

MLA (9th ed.) Citation

Wehling, Cyrill, and Michael Kirschfink. "Tailored Eculizumab Regimen for Patients with Atypical Hemolytic Uremic Syndrome: Requirement for Comprehensive Complement Analysis." Journal of Thrombosis and Haemostasis, vol. 12, no. 9, 2014, https://doi.org/10.1111/jth.12639.